Department of Genetics, Faculty of Biology, University of Santiago de Compostela, Santiago de Compostela, Spain.
Proteomics Clin Appl. 2007 Sep;1(9):983-1003. doi: 10.1002/prca.200700086. Epub 2007 Aug 17.
This review summarises and discusses the degree to which proteomics is contributing to medical care, providing examples and signspots for future directions. Why do genomic approaches provide a limited view of gene expression? Because of the multifactorial nature of many diseases, proteomics enables us to understand the molecular basis of disease, not only at the organism, whole-cell or tissue levels, but also in subcellular structures, protein complexes and biological fluids. The application of proteomics in medicine is expected to have a major impact by providing an integrated view of individual disease processes. This review describes several proteomic platforms and examines the role of proteomics as a tool for clinical biomarker discovery, the identification of prognostic and earlier diagnostic markers, their use in monitoring the effects of drug treatments and eventually find more efficient and safer therapeutics for a wide range of pathologies.
这篇综述总结并讨论了蛋白质组学在医疗中的贡献程度,为未来的方向提供了实例和信号点。为什么基因组方法提供的基因表达观点有限?由于许多疾病的多因素性质,蛋白质组学使我们能够了解疾病的分子基础,不仅在器官、全细胞或组织水平,而且在亚细胞结构、蛋白质复合物和生物体液中。蛋白质组学在医学中的应用有望通过提供对个体疾病过程的综合观点产生重大影响。本综述描述了几种蛋白质组学平台,并探讨了蛋白质组学作为临床生物标志物发现工具的作用,确定预后和早期诊断标志物,以及它们在监测药物治疗效果中的应用,最终为广泛的病理提供更有效和更安全的治疗方法。